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Abstract
Gadopentetate dimeglumine (Gd-DTPA)–based dynamic contrast-enhanced magnetic resonance imaging (DCE-
MRI) is considered to be a useful method for characterizing the vascularity of tumors. However, detailed studies
of experimental tumors comparing DCE-MRI–derived parametric images with images of the morphology and
function of the microvascular network have not been reported. In this communication, we describe a novel MR-
compatible mouse dorsal window chamber and report comparative DCE-MRI and intravital microscopy studies of
A-07-GFP tumors xenografted to BALB/c nu/numice. Blood supply time (BST) images (i.e., images of the time from
when arterial blood enters a tumor through the supplying artery until it reaches a vessel segment within the tumor)
and morphologic images of the microvascular network were produced by intravital microscopy. Images of E·F (E is
the initial extraction fraction of Gd-DTPA and F is perfusion) were produced by subjecting DCE-MRI series to Kety
analysis. The E·F images mirrored the morphology (microvascular density) and the function (BST) of the micro-
vascular networks well. Tumor regions showing high E·F values colocalized with tumor regions showing high
microvascular density and low BST values. Significant correlations were found between E·F and microvascular
density and between E·F and BST, both within and among tumors.
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Introduction
Human and experimental tumors develop a highly heterogeneous
physiological microenvironment during growth characterized by oxy-
gen and nutrient depletion, low energy status, extracellular acidosis,
and interstitial hypertension [1]. This hostile microenvironment
causes resistance to treatment and may promote malignant progres-
sion, invasive growth, and metastatic dissemination [2,3]. The physio-
logical parameters of the tumor microenvironment are determined
primarily by the blood perfusion, which is inadequate and heteroge-
neous in most tumors, primarily because of severe structural and archi-
tectural abnormalities in the microvascular network [1–4].
It has been suggested that gadopentetate dimeglumine (Gd-DTPA)–
based dynamic contrast-enhanced magnetic resonance imaging (DCE-
MRI) may be a useful noninvasive diagnostic method for characterizing
the vascularity of tumors. The uptake of Gd-DTPA in tumor tissue de-
pends on several vascular and nonvascular parameters, including blood
perfusion, microvascular density, vessel wall permeability, cell density,
extracellular volume fraction, and extracellular matrix density [5]. A
variety of qualitative, semiquantitative, and quantitative strategies are
being used for analyzing DCE-MRI series of tumors [6]. The most
promising quantitative methods are based on the use of pharmacoki-
netic models of the uptake of Gd-DTPA in the tumor tissue [6,7].
However, the parameters derived from these models describe the ki-
netics of Gd-DTPA distribution rather than true tumor physiology
and are thus only surrogate parameters for physiological parameters.
Abbreviations: BST, blood supply time; DCE-MRI, dynamic contrast-enhanced mag-
netic resonance imaging; E·F, extraction-perfusion product, where E is the initial ex-
traction fraction of Gd-DTPA and F is blood perfusion; Gd-DTPA, gadopentetate
dimeglumine; GFP, green fluorescence protein; K trans, volume transfer constant of
Gd-DTPA; ROI, region of interest; TRITC, tetramethylrhodamine isothiocyanate;
ve, distribution volume of Gd-DTPA per unit volume of tissue; λ, partition coefficient
of Gd-DTPA
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It is thus generally accepted that the validity of the DCE-MRI–derived
parameters and parametric images used for characterizing the physiologi-
cal microenvironment of tumors needs to be evaluated carefully [6,7].
A commonly used evaluation strategy is to compare DCE-MRI–
derived parameters with histologic parameters of the imaged tumors
[8–13]. Thus, correlations have been found between DCE-MRI–
derived parameters and microvascular density in breast carcinoma [8],
cervical carcinoma [9], and cerebral glioma [10]. Moreover, DCE-
MRI–derived parameters have been shown to correlate with the expres-
sion of vascular endothelial growth factor-A in breast carcinoma [11,12]
and colorectal carcinoma [13]. However, the correlations were, in gen-
eral, weak possibly because the DCE-MRI–derived parameters used in
these studies were not adequate measures of tumor vascularity or be-
cause the biopsies used for preparation of histologic sections were not
representative for the imaged tissue.
The potential usefulness of Gd-DTPA–based DCE-MRI in charac-
terizing the microenvironment of tumors is currently being evaluated
in our laboratory by using human tumor xenografts as preclinical
models of human cancer [14–17]. Our studies have shown that high-
ly reproducible images of E·F (E is the initial extraction fraction
of Gd-DTPA and F is blood perfusion) and λ (λ is proportional to
extracellular volume fraction) can be obtained by subjecting DCE-
MRI series to Kety analysis [14,15]. We have also performed experi-
ments showing that E·F may be correlated to microvascular density
and fraction of radiobiologically hypoxic cells in human melanoma
xenografts [16,17]. These experiments provided significant evidence
that DCE-MRI may be a useful imaging method for characterizing
the microenvironment of tumors. However, because microvascular
density is a global parameter and measurement of fraction of radio-
biologically hypoxic cells requires tumor disaggregation, our studies
did not allow a direct comparison of E·F images and images of the
tumor microenvironment.
Detailed studies of the microenvironment of tumors can be per-
formed by the use of window chamber preparations and intravital
microscopy techniques [18–22]. These methods are particularly use-
ful for providing high-resolution images of the morphology and func-
tion of tumor microvascular networks. DCE-MRI studies of tumors
growing in window chamber preparations have not been reported
thus far, probably because MR-compatible window chambers are
not available. An MR-compatible mouse dorsal window chamber
was recently constructed by the Group of Radiation Biology and Tu-
mor Physiology at the Norwegian Radium Hospital. In the present
communication, we describe this window chamber and report com-
prehensive studies comparing DCE-MRI–derived E·F images with
optical images of tumor vascularity. The main purpose of the work
was to investigate to what extent E·F images reflect morphologic and
functional images of the microvascular network of tumors. The mor-
phologic parameters used in our work included vessel length density,
vascular area fraction, and interstitial distance, whereas blood supply
time [BST (i.e., the time required for arterial blood to flow from the
main tumor-supplying artery to a downstream tumor microvessel
segment)] [23] was used as functional parameter.
Materials and Methods
Mice
Adult (8–10 weeks of age) female BALB/c nu/nu mice, bred and
maintained as described elsewhere [23], were used as host animals
for dorsal window chamber preparations. The animal experiments
were approved by the Institutional Committee on Research Animal
Care and were done according to the Interdisciplinary Principles and
Guidelines for the Use of Animals in Research, Marketing, and Edu-
cation (New York Academy of Sciences, New York, NY).
Cells and Multicellular Spheroids
A-07 human melanoma cells [24] were constitutively transfected
with green fluorescence protein (GFP) by lipofection. The transfected
cells (A-07-GFP) were grown as monolayers in RPMI 1640 (25 mM
HEPES and l-glutamine) supplemented with 13% bovine calf serum,
700 μg/ml genetecin, 250 μg/ml penicillin, and 50 μg/ml streptomy-
cin. Multicellular spheroids of A-07-GFP cells were produced and
maintained by using a liquid-overlay culture technique [25]. Monolayer
cultures and spheroids were incubated at 37°C in a humidified atmo-
sphere of 5% CO2 in air and subcultured twice a week.
Anesthesia
Window chamber implantation, intravital microscopy, and DCE-
MRI were carried out with anesthetized mice. Fentanyl citrate (Janssen
Pharmaceutica, Beerse, Belgium), fluanisone (Janssen Pharmaceutica),
and midazolam (Hoffmann-La Roche, Basel, Switzerland) were ad-
ministered i.p. in doses of 0.63, 20, and 10 mg/kg, respectively.
Window Chamber Preparations
Window chambers were implanted into the dorsal skin fold of mice
by using a procedure similar to that described by Papenfuss et al. [26].
Briefly, the chamber consisted of parallel frames, and after implanta-
tion, these frames sandwiched an extended double layer of skin (Fig-
ure 1). Before the chamber was implanted, a circular hole with a
diameter of ∼6.0 mm was made in one of the skin layers. A plastic
window with a diameter of 6.0 mm was attached to the frame
on the surgical side with a clip to provide visual access to the fas-
cial side of the opposite skin layer. The frames and the clip were in-
house-made of polymer material (Victrex PEEK; Victrex Technology
Centre, Thornton Cleveleys, UK). The composite chamber had a
total weight of 1.0 g. Tumors were initiated by implanting an
A-07-GFP spheroid with a diameter of 100 to 200 μm onto the fas-
cial side of the intact skin layer. After surgery, the mice were given
buprenorphine (Temgesic; Schering-Plough, Brussels, Belgium) i.p.
in a dose of 0.12 mg/kg.
Intravital Microscopy
Tumor vascular morphology and blood flow were imaged by using
an inverted fluorescence microscope equipped with filters for green
and red lights (IX-71; Olympus, Munich, Germany), a black and
white CCD camera (C4742-95; Hamamatsu Photonics, Hamamatsu,
Japan), and appropriate image acquisition software (Wasabi; Hamamatsu
Photonics). Tetramethylrhodamine isothiocyanate dextran (TRITC-
dextran) with a molecular weight of 155 kDa (Sigma Aldrich, St.
Louis, MO) was used as vascular tracer. A 0.2-ml bolus of TRITC-
dextran (50 mg/ml) was injected into the lateral tail vein, and first-
pass imaging movies were recorded at a frame rate of 18 frames per
second (fps) by using a ×1.25 objective lens, resulting in a time reso-
lution of 55.6 milliseconds, a field of view of 6.89 × 5.51 mm2, and
a pixel size of 10.8 × 10.8 μm2. Afterwards, the entire vasculature
network was mapped by recording 9 to 16 single frames with a ×4
objective lens, resulting in a field of view of 2.15 × 1.72 mm2 and
a pixel size of 3.4 × 3.4 μm2. During imaging, the mice were kept
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in a specially constructed holder that fixed the window chamber to the
microscope stage. The body core temperature of the mice was kept at
37 to 38°C by using a hot-air generator. The recordings were stored
and analyzed offline. Tumor size (i.e., tumor area) was calculated from
the number of pixels showing GFP fluorescence.
Vascular Masks and BST Images
Two-dimensional projected vascular masks were established from
stored images by using an in-house-made computer program. The
algorithms used for identification of microvascular networks were im-
plemented in MATLAB software (The MathWorks, Natick, MA).
Background heterogeneities were removed by using a white top hat
transformation. The images were eroded by linear structure elements,
and local thresholding was carried out. Finally, the images were
cleaned up by applying scrapping and hole filling procedures. Vascu-
lar masks established from high-resolution images (i.e., images re-
corded by a ×4 objective lens) were used to compute morphologic
parameters. The following morphologic parameters were computed:
total vessel length per μm2 tumor area, length of large vessels (i.e.,
vessels with diameter ≥23.8 μm, corresponding to 7 pixels) per μm2
tumor area, vascular area fraction [i.e., # pixels (vascular mask)/#
pixels (tumor)], and interstitial distance (i.e., the median of the dis-
tance from a tumor pixel outside the vascular mask to the nearest
pixel within the vascular mask). Blood supply time images were pro-
duced by assigning a BST value to each pixel of the vascular masks.
The BST of a pixel was measured as the time difference between the
frame showing maximum fluorescence intensity in the pixel and the
frame showing maximum fluorescence intensity in the main tumor-
supplying artery, as described in detail previously [23].
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
DCE-MRI was performed by using a procedure similar to that
described in great detail elsewhere [17]. Briefly, a 1.5-T whole-body
scanner (Signa; General Electric, Milwaukee, WI) and a cylindrical
slotted tube resonator transceiver coil especially constructed for mice
[27] were used for imaging. The tumors were imaged sagittally in a
single scan adjacent to and parallel to the window of the chamber pre-
parations at a voxel size of 0.31 × 0.31 × 2.0 mm3 and with a time
resolution of 14 seconds. The sequences of the DCE-MRI sessions
have been described previously [17]. Tumor size (i.e., tumor area)
was calculated from the number of pixels showing Gd-DTPA–induced
contrast enhancement in T1-weighted images.
Analysis of DCE-MRI Data
The DCE-MRI series were subjected to Kety analysis as described
in detail previously [14–17]. Briefly, Gd-DTPA concentrations were
calculated from signal intensities by using the method of Hittmair
et al. [28]. Plots of Gd-DTPA concentration versus time were gener-
ated, and the Kety equation [29],
CtðT Þ ¼ E F 
ZT
0
CaðtÞe−E F ðT −tÞ=λdt;
was fitted to the plots, where Ct(T ) is the Gd-DTPA concentration
in the tumor tissue at time T, E is the initial extraction fraction of
Gd-DTPA, F is the perfusion per unit tumor volume, Ca(t) is the
arterial input function, and λ represents the partition coefficient of
Gd-DTPA and is proportional to the extracellular volume fraction.
The arterial input function was determined as described elsewhere
[14,30]. Numerical values of E·F [in ml/g per minute] and λ were
determined for each voxel from the best curve fit. The uncertainty
in the assessment of E·F and λ was investigated by subjecting the
DCE-MRI data to Monte Carlo analysis, using noise generated from
the residuals of the Kety curve fits [30]. The standard deviation of
E·F was found to be less than 0.005 ml/g per minute for all values of
E·F, whereas λ showed a standard deviation that increased from
0.007 to 0.012 with increasing E·F value.
Figure 1. (A) Technical drawing of our MR-compatible mouse
dorsal window chamber. The chamber consists of a clip (i), a sili-
con ring (ii), a transparent plastic window with a diameter of
6.0 mm (iii), and three frames (iv–vi). The frames and the clip were
in-house-made of polymer material (Victrex PEEK; Victrex Tech-
nology Centre). The chamber has an outer diameter of 19.0 mm,
an outer thickness of 7.0 mm, and a total weight of 1.0 g. (B) Pho-
tograph of the MR-compatible chamber implanted in the dorsal
skin fold of a BALB/c nu/nu mouse. The tumor vasculature is visi-
ble through the transparent window. (C) A low-magnification gra-
dient echo image showing the calibration phantoms (P) and a
mouse bearing a window chamber (WC) with an A-07-GFP tumor
(T) (left) and a high-magnification image of the outlined region,
showing the tumor (right).
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Statistical Analysis
Correlations between two parameters were searched for by linear
regression analysis. Probability values (P) and correlation coefficients
(R) were calculated by using the SigmaStat statistical software (SPSS
Science, Chicago, IL). A significance criterion of P < .05 was used.
Results
An MR-compatible mouse dorsal window chamber was con-
structed and produced (Figure 1A), and eleven A-07-GFP tumors
were transplanted to the chamber and examined. The tumors grew
as a hemisphere in the chamber, with the plane surface facing the
window (Figure 1B). When the area of this surface had grown to a
size of 10 to 30 mm2, a bolus of TRITC-dextran was administered
i.v., and a first-pass imaging movie of the entire tumor surface was
recorded before the microvascular network was mapped at a higher
magnification. The tumors were subjected to DCE-MRI ∼6 hours
later. The chamber did not induce artifacts in the MR images of
the tumors (Figure 1C ).
The tumors differed substantially in vascularity. This is illustrated
in Figure 2, which shows the intravital microscopy image of the
microvascular network, the DCE-MRI–derived E·F image, and the
E·F frequency distribution of a homogeneous and well-vascularized
tumor (Figure 2A) and a heterogeneous and poorly vascularized
tumor (Figure 2B).
To compute morphologic parameters from microvascular network
images, vascular masks were made from the images (i.e., pixels within
and outside the network were given the values 1 and 0, respectively).
The general quality of the masks is illustrated in Figure 3, which
shows low- and high-magnification images of a microvascular net-
work (Figure 3A), low- and high-magnification binary images of
the corresponding vascular mask (Figure 3B), and low- and high-
magnification images of the contour of the vascular mask superim-
posed on low- and high-magnification images of the microvascular
network (Figure 3C ).
Quantitative analysis of the vascular masks showed that the micro-
vascular density differed substantially among the eleven tumors.
Thus, total vessel length per unit tumor area ranged from 0.013 to
0.025 per μm with a mean value of 0.018 per μm, length of large
vessels per unit tumor area ranged from 0.0080 to 0.0099 per μm
with a mean value of 0.0091 per μm, vascular area fraction ranged
from 0.36 to 0.42 with a mean value of 0.39, and interstitial distance
ranged from 10.6 to 21.5 μm with a mean value of 15.5 μm. In com-
parison, median E·F of the tumors ranged from 0.40 to 1.31 ml/g per
minute with a mean value of 0.76 ml/g per minute.
A detailed comparison of intravital microscopy images and DCE-
MRI–derived images requires that the tumor size is identical in the
two types of images. There was a nearly one-to-one correlation be-
tween the tumor area determined from the GFP-signal in the intra-
vital microscopy experiments and the tumor area determined from
the Gd-DTPA–induced contrast enhancement in the DCE-MRI ex-
periments. This is illustrated in Figure 4A, which shows tumor area
measured by DCE-MRI versus tumor area measured by intravital
microscopy (R2 = 0.91; P = .000006).
Correlations between E·F and morphologic parameters of the mi-
crovasculature were searched for at three levels: by calculating numer-
ical values of E·F and morphologic parameters for whole tumors, for
three concentric circular regions of interest (ROIs), and for quadratic
ROIs corresponding to 4 × 4 E·F pixels. The morphologic images
and the E·F images were divided into circular and quadratic ROIs
as illustrated in Figure 4B (left and right, respectively). The tumor
used as example showed radial heterogeneity in E·F and microvascu-
lar density. Both E·F and vascular area fraction were highest in the
peripheral ROI, second highest in the middle ROI, and lowest in the
central ROI (Figure 4B, left). Moreover, there was a significant cor-
relation between E·F and vascular area fraction for the quadratic
Figure 2. Intravital microscopy images of the microvascular network (left panels), DCE-MRI–derived E·F images (middle panels), and the
corresponding E·F frequency distributions (right panels) of a homogeneous and well-vascularized A-07-GFP tumor (A) and a heteroge-
neous and poorly vascularized A-07-GFP tumor (B). The color bars show the E·F scales. The vertical lines in the E·F frequency distribu-
tions indicate median E·F. Scale bars, 1 mm.
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ROIs (Figure 4B, right; R2 = 0.35; P = .016). Similar correlations were
found for all heterogeneous tumors. Thus, when the quadratic ROIs
differed significantly in E·F (i.e., when the differences in E·F among
the ROIs were large compared with the experimental uncertainty in
E·F ), E·F increased significantly with increasing microvascular density.
However, for homogeneous tumors (i.e., when the differences in E·F
among the quadratic ROIs were similar to the experimental uncer-
tainty in E·F ), significant correlations between E·F and one or more
of the morphologic parameters could not be detected.
The data for all 11 tumors are summarized in Figure 4C. With
only two exceptions, significant correlations were found between
E·F and microvascular density, regardless of whether the analysis
was based on whole tumors (left column), circular ROIs (middle col-
umn), or quadratic ROIs (right column), and regardless of whether
total vessel length per μm2 tumor area (first row), length of large ves-
sels per μm2 tumor area (second row), vascular area fraction (third
row), or interstitial distance (fourth row) was used as parameter for
microvascular density. The exceptions were E·F versus total vessel
length per μm2 tumor area (whole tumors) and E·F versus interstitial
distance (whole tumors). The strongest correlations were found when
microvascular density was measured as length of large vessels per μm2
tumor area [R2 = 0.81, P = .00014 (whole tumors); R2 = 0.56, P <
.000001 (circular ROIs); R2 = 0.39, P < .000001 (quadratic ROIs)].
There was no correlation between E·F and vessel diameter (P > .05)
or between E·F and tumor size (P > .05).
Moreover, E·F was inversely correlated to BST. This is illustrated
qualitatively in Figure 5, which shows single frames from the first-pass
imaging movie, the E·F image, and the E·F frequency distribution of
a well-vascularized (Figure 5A) and a poorly vascularized (Figure 5B)
tumor. The entire microvascular network of the well-vascularized
tumor was filled with TRITC-dextran 1.3 seconds after the bolus
had reached the main tumor-supplying artery, and the E·F values were
high in all regions of the tumor. In the poorly vascularized tumor, on
the other hand, a large central region of the microvascular network was
not filled with TRITC-dextran even 5 seconds after the bolus had
reached the main tumor-supplying artery, and this region of the tumor
showed low E·F values.
The correlation between E·F and BST is illustrated quantitatively
in Figure 6 by using a heterogeneously vascularized tumor as exam-
ple. The figure shows two single frames from the first-pass imaging
movie of the tumor and curves for relative signal intensity versus time
for the ROIs indicated in the frames (Figure 6A), the BST image and
the BST frequency distribution of the tumor (Figure 6B), the E·F
image and the E·F frequency distribution of the tumor (Figure 6C ),
and curves for E·F versus BST (Figure 6D). The curves in Figure 6A
refer to a ∼30-pixel-large ROI in the main supplying artery and single
pixels in a tumor arteriole, a tumor capillary, and a tumor venule.
These curves illustrate the sensitivity of the BST calculations, as the
BST values of the pixels in the tumor arteriole, tumor capillary, and
tumor venule are given by the time difference between the peaks of the
red and black curves, the green and black curves, and the blue and
black curves, respectively. A BST value was assigned to each pixel in
the vascular mask, giving rise to the BST image and the BST frequency
distribution in Figure 6B. The BST image showed high BST values in
the same tumor regions as the E·F image showed low E·F values and
vice versa. There was a significant inverse linear correlation between
E·F and BST, both when the images were divided into 8 ROIs with
a size corresponding to 4 × 4 E·F pixels (Figure 6D, left; R2 = 0.75; P =
.0053) and 32 ROIs with a size corresponding to 2 × 2 E·F pixels
(Figure 6D, right; R2 = 0.35; P = .00037).
Discussion
Comparative examinations of DCE-MRI–derived parametric
images and intravital microscopy-derived morphologic and functional
images of the microvasculature of tumors have not been reported pre-
viously, probably because current window chambers are made of tita-
nium frames with screws and nuts of stainless steel and thus are
MR-incompatible. In the work reported here, we present a novel
in-house-made MR-compatible window chamber that does not induce
artifacts in MR images of tumors growing in the chamber. Thus, high-
resolution E·F images of the tumors can be produced, and because
the chamber was equipped with a plastic window providing excellent
visual access to the tissue in the chamber, detailed optical images of the
morphology and function of the microvascular network can be pro-
vided by using intravital microscopy techniques.
Several studies have indicated that window chamber tumors grow-
ing as a thin sheet between two windows may differ physiologically
from tumors with a spherical shape growing in the intradermal or
Figure 3. Intravital microscopy images of the microvascular net-
work (A), binary images of the corresponding vascular mask (B),
and images showing the contour of the vascular mask superim-
posed on the microvascular network (C) of a homogeneous and
well-vascularized A-07-GFP tumor. The panels to the left refer to
the entire microvascular network of the tumor. The panels to the
right show high-magnification images of the outlined region. Scale
bars, 1 mm.
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subcutaneous space [18–21]. Thus, the interstitial fluid pressure may
be higher in two-dimensional window chamber tumors than in
three-dimensional subcutaneous tumors because the windows may
restrict the flow of interstitial fluid from the tumor tissue to the sur-
rounding normal tissue. To limit the proportions of possible chamber-
induced physiological changes in the tumor tissue, the A-07-GFP
tumors studied here were grown as a hemisphere in a chamber with
a single window, with the plane surface facing the window. When the
chamber was removed after an experiment, skin discoloration or tis-
sue swelling was not seen, in contrast to what has been observed for
two-window chambers. Moreover, studies in our laboratory of A-07-
GFP window chamber tumors similar to those studied here have shown
Figure 4. E·F derived by DCE-MRI versus microvascular density derived by intravital microscopy for eleven A-07-GFP tumors. (A) Tumor
area measured by DCE-MRI versus tumor area measured by intravital microscopy (IVM). (B) Intravital microscopy images of the micro-
vascular network (upper panels), E·F images (middle panels), and plots of E·F versus vascular area fraction (lower panels) for a hetero-
geneous and poorly vascularized tumor. The images illustrate how the tumors were divided into three concentric circular ROIs and
quadratic ROIs. The circular ROIs are bounded by lines drawn at distances of nR/3 from the tumor center, where R is tumor radius
and n is ROI number. The size of the quadratic ROIs corresponds to 4 × 4 E·F pixels (i.e., 1.24 × 1.24 mm2). The E·F scale is given
by the color bar. Scale bars, 1 mm. The plots show median E·F versus vascular area fraction for the three circular ROIs (left panel) and
the sixteen quadratic ROIs (right panel). (C) Plots of median E·F versus microvascular density. The symbols represent individual tumors
(left panels), individual circular ROIs (middle panels), and individual quadratic ROIs (right panels). Peripheral quadratic ROIs consisting of
<75% tumor pixels were not included in the analysis. The parameters used for microvascular density are total vessel length per μm2
tumor area (first row), length of large vessels (i.e., vessels with diameter ≥23.8 μm, corresponding to 7 pixels) per μm2 tumor area
(second row), vascular area fraction [i.e., # pixels (vascular mask)/# pixels (tumor); third row], and interstitial distance (i.e., the median
of the distance from a tumor pixel outside the vascular mask to the nearest pixel within the vascular mask; fourth row). Solid lines
represent significant correlations and were fitted to the data by linear regression analysis.
Neoplasia Vol. 10, No. 4, 2008 Tumor Vascularity Gaustad et al. 359
that (1) the tumors have an interstitial fluid pressure that is similar to
that measured in intradermal A-07 tumors and (2) the tumors do not
possess hypoxic regions (i.e., regions staining positive for the hypoxia
marker pimonidazole cannot be detected in histologic preparations
of the tissue) [unpublished data]. Consequently, it is highly unlikely
that our chamber induced an artificially high interstitial fluid pres-
sure and hypoxia in the tumor tissue that led to hypoxia-induced
secretion of proangiogenic factors, elevated angiogenic activity, and
increased blood perfusion.
Different strategies are being used for deriving relevant kinetic
parameters from DCE-MRI series [6]. The principal approaches
make use of pharmacokinetic models, assuming that the transvascular
flux of contrast agent is limited purely by blood flow, purely by vessel
permeability, or by both blood flow and vessel permeability. The
Kety model assumes that the uptake of Gd-DTPA in tissues is gov-
erned primarily by the blood perfusion. It is highly probable that this
assumption is valid for the A-07-GFP tumors examined here, as sev-
eral independent studies suggest that the transvascular flux of Gd-
DTPA in A-07 tumors is not limited by the permeability of the mi-
crovessel wall. Thus, electron microscopy examinations have shown
that the microvasculature of A-07 tumors has severe structural abnor-
malities, including high frequency of endothelial fenestrae and large
interendothelial gaps, incomplete endothelial lining, and discontinu-
ous basement membrane, and thus should be highly permeable to
low-molecular-weight hydrophilic contrast agents such as Gd-DTPA
Figure 5. Three single frames from the first-pass imaging movie, the
E·F image, and the E·F frequency distribution of a well-vascularized
(A) and a poorly vascularized (B) A-07-GFP tumor. The frames were
recorded 0.2, 0.4, and 1.3 seconds (A) and 2, 5, and 20 seconds (B)
after the TRITC-dextran bolus had reached the main tumor-supplying
artery. The color bars show the E·F scales. The vertical lines in the
E·F frequency distributions indicate median E·F. Scale bars, 1 mm.
Figure 6. The figure refers to a heterogeneously vascularized A-07-
GFP tumor and shows two single frames from the first-pass imag-
ing movie, recorded 0.6 and 2.8 seconds after the bolus had
reached the main tumor-supplying artery, and curves for relative sig-
nal intensity versus time for the ROIs indicated in the frames (A), the
BST image and the BST frequency distribution (B), the E·F image
and the E·F frequency distribution (C), and plots of E·F versus BST
(D). The ROIs and curves in (A) refer to the main supplying artery
(MSA), a tumor arteriole (TA), a tumor capillary (TC), and a tumor
venule (TV). The scales of the BST and E·F images are given by
the color bars. The vertical lines in the BST and E·F frequency dis-
tributions indicate median BST and median E·F. Scale bars, 1 mm.
The plots show median E·F versus median BST for quadratic ROIs
with a size corresponding to 4 × 4 (left panel) or 2 × 2 (right panel)
E·F pixels (i.e., 1.24 × 1.24 and 0.62 × 0.62 mm2, respectively). The
symbols represent individual ROIs. The solid lines represent curves
fitted to the data by linear regression analysis.
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[24]. Bioscope imaging studies have demonstrated that the intra-
tumor heterogeneity in the uptake of freely diffusible radioactive
blood flow tracers is similar to that of Gd-DTPA in A-07 tumors, sug-
gesting that the E for Gd-DTPA is uniformly close to unity [31].
Moreover, DCE-MRI measurements have revealed that the effec-
tive microvascular permeability constants for macromolecules and
20-nm-diameter superparamagnetic iron oxide particles are extremely
high in A-07 tumors [32,33].
The most commonly used pharmacokinetic model for analyzing
DCE-MRI data of tumors is the model known as the generalized ki-
netic model of Tofts [6]. This model is the model of choice when
studying tumors with low, unknown, or heterogeneous microvascular
permeability for Gd-DTPA. The parameters of the Kety model (E·F
and λ) are related to the parameters of the Tofts model [K trans (the
volume transfer constant of Gd-DTPA) and ve (the distribution vol-
ume of Gd-DTPA per unit volume of tissue)] by the following ex-
pressions: E·F = K trans/[ρ · (1 − Hct)] and λ = ve/[ρ · (1 − Hct)],
where ρ is the density of the tissue and Hct is the hematocrit. In
the present communication, we chose to use the Kety formulation,
primarily because E·F is preferable to K trans as a parameter for tumor
vascularity in tumors where the uptake of Gd-DTPA is known to
be limited purely by the blood flow. K trans has a per-minute unit
and is simply a rate constant with no direct physical or physiological
meaning. Conversely, the unit of E·F is ml/g per minute, implying
that numerical values of E·F can be compared directly with numer-
ical values of tumor blood perfusion. In an earlier study of 200- to
700-mm3 intradermal A-07 tumors, median E·F was found to range
from 0.05 to 0.39 ml/g per minute with a mean value of 0.20 ml/g
per minute [17]. Interestingly, these values are similar to those
achieved when tumor blood perfusion was measured with inva-
sive methods in intradermal A-07 tumors [34]. Median E·F of the
tumors studied here ranged from 0.40 to 1.31 ml/g per minute with
a mean value of 0.76 ml/g per minute and was thus higher than those
mentioned above, most likely because the window chamber tumors
studied here were substantially smaller than the intradermal tumors
studied earlier. This suggestion is consistent with the observation
that intradermal A-07 tumors with volume >200 mm3 have a mean
fraction of radiobiologically hypoxic cells of 5% to 10% [16,35],
whereas radiobiologically hypoxic cells cannot be detected in intra-
dermal A-07 tumor with volume <200 mm3 [36].
The DCE-MRI was performed by using a voxel size of 0.31 ×
0.31 × 2.0 mm3 and a time resolution of 14 seconds. Previous studies
in our laboratory of intradermal A-07 tumors have shown that the
signal-to-noise ratio at this voxel size is sufficiently high to provide
well-defined Gd-DTPA concentration versus time curves and that the
initial rising part of the Kety curves is determined precisely at this
time resolution [14,16,17,30]. These observations were confirmed
in the present study of A-07-GFP window chamber tumors.
Adequate evaluation of the usefulness of DCE-MRI in character-
izing the vascularity of tumors requires comparisons of DCE-MRI–
derived parameters with morphologic as well as functional parameters
of the microvascular network. Several morphologic and functional
parameters are being used for describing the microvascular network
of tumors growing in window chambers [18–21]. In the work re-
ported here, microvascular density, measured as total vessel length
per μm2 tumor area, length of large vessels per μm2 tumor area, vas-
cular area fraction, and interstitial distance, was used as morphologic
parameter, and BST was used as functional parameter. By using these
parameters, it was possible to characterize the morphology and function
of the microvascular network of the tumors in a single experiment, and
most importantly, our strategy made it possible to compare DCE-
MRI–derived parametric images with morphologic and functional
microvascular images of whole tumors.
The calculation of microvascular density and the computation of
BST images required production of vascular masks. As demonstrated
in Figure 3, our algorithms produced vascular masks of high quality
(i.e., small vessels were detected as well as large vessels, and the diameter
of the vessels was retained in the masks). A weakness of our approach
is, however, that the vascular masks represented two-dimensional pro-
jections of the three-dimensional tumor vasculature. Calculation of
microvascular density from two-dimensional vascular masks results in
an overestimation of the microvascular density because of contributions
from out-of-plane vasculature. The magnitude of the overestimation
may depend on the parameter used for microvascular density, and con-
sequently, four different parameters were used for microvascular density
in the present work. However, when comparing DCE-MRI–derived
parametric images with intravital microscopy-derived images of tumor
vascularity, high depth resolution of the intravital microscopy images is
not crucial because MR scans also have a substantial thickness (2 mm
in the study reported here).
The function of the tumor microvascular networks was assessed by
measuring BST. Previous work has shown that this parameter can be
measured with high accuracy in any pixel within the vascular net-
work of tumors growing in ∼250-μm-thick window chamber pre-
parations and that a time resolution of 55.6 milliseconds (18 fps)
is sufficient to demonstrate that BST increases gradually along in-
dividual vessel segments in the tumor tissue [23]. In the present
work, we demonstrate that BST can be assessed with similar accuracy
also in many hemispherical window chamber tumors, as illustrated in
Figure 6. The calculation of high-quality BST images requires that
the great majority of the pixels within the vascular mask show fluo-
rescence intensity versus time curves with a well-defined peak (cf.,
Figure 6A, right panel). However, this requirement was not fulfilled
in all hemispherical tumors studied here. Some tumors, particularly
large tumors with highly irregular microvascular networks, showed
regions with very delayed blood supply (i.e., regions that were not
reached by the TRITC-dextran bolus until after a lag time of up
to 20 seconds), as illustrated in Figure 5B. The peak of the fluores-
cence intensity versus time curves in these regions was poorly defined,
and consequently, it was not possible to produce high-quality BST
images and frequency distributions. For these tumors, only rough es-
timates of the BST values could be produced from the delay in con-
trast appearance.
If E·F is going to be a clinically useful parameter for noninvasive char-
acterization of the vascularity of tumors, images of E·F have to reflect
morphologic and functional images of the tumor microvasculature. Ide-
ally, significant correlations between E·F and microvascular parameters
should exist within heterogeneous tumors as well as across individual
tumors, both for whole tumors and tumor subregions. Our study
showed unequivocally that E·F images mirror morphologic and func-
tional images of the microvasculature of A-07-GFP tumors well. Thus,
strong correlations were found between E·F and microvascular den-
sity, both for whole tumors and tumor subregions, regardless of whether
microvascular density was measured as total vessel length per μm2 tumor
area, length of large vessels per μm2 tumor area, vascular area fraction,
or interstitial distance. Interestingly, E·F showed the strongest correla-
tion with the density of large-diameter vessels, possibly because tumor
blood perfusion is influenced strongly by these vessels. Moreover, E·F
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was found to reflect the intratumor and intertumor heterogeneity in
BST. Thus, tumors showing high and homogeneous E·F values showed
low and homogeneous BST values. In heterogeneous tumors, regions
showing high E·F values colocalized with regions showing low BST val-
ues and regions showing low E·F values colocalized with regions show-
ing high BST values, regardless of whether BSTwas assessed accurately
or just estimated from the delay in contrast appearance.
In conclusion, the work reported here strongly suggests that paramet-
ric images providing information on the morphology and function of
the microvasculature of tumors can be obtained by Gd-DTPA–based
DCE-MRI. The possibility that DCE-MRI may be developed to be
a useful noninvasive diagnostic method for characterizing the micro-
vasculature of human tumors merits clinical investigation.
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